UNSPSC 85481421: Supplement femoral nerve with autologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement femoral nerve with autologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 01UD37Z

UNSPSC 85481421, Supplement femoral nerve with autologous tissue substitute, percutaneous approach, is a Commodity code that shows no alignment with actual state and local procurement activity in the recent opportunities block. The code describes a specific orthopedic surgical procedure; however, the six posted opportunities under this code span independent medical evaluation services for public safety pension boards, surgical benefit carve-out programs for municipal employees, occupational medical surveillance for ferry workers, emergency and specialty healthcare for detained youth, pharmacy benefit management administration, and temporary health professional staffing — none of which involve femoral nerve supplementation or autologous tissue substitution. The mismatch suggests either a data-quality issue in how opportunities were tagged to the code or that this Commodity code does not reflect active state and local procurement in the current market.

The opportunities that do appear under the code originate from diverse issuing bodies including city retirement offices and municipal health plans (Phoenix, Long Beach), state transportation departments (Washington State Department of Transportation), county health systems and probation departments (Santa Clara, Harris County), and county human resources divisions (Collier County). Recent activity concentrates in California, Arizona, Washington, and Texas, with response dates spanning September through October 2026. However, since these solicitations bear no substantive relationship to the code's nominal scope, the code itself should not be treated as a useful procurement signal for vendors specializing in orthopedic surgical services or tissue-substitute procedures.